Multicenter CSF analysis with flow cytometry in patients with aggressive B cell lymphoma at risk for central nervous relapse: retrospective analysis of the clinical outcome of 60 patients

被引：0
|
作者：
Stuhlmann, R. [1 ]
Kleinert, C. [1 ]
Hauspurg, H. [1 ]
Zeis, M. [1 ]
Schmitz, N. [1 ]
机构：
[1] Asklepios Klin St Georg, Hamburg, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [21] Malignant Childhood Central Nervous Sytem Tumors: Retrospective Analysis of 60 Patients
    Yagci-Kupeli, B.
    Okten, I.
    Gezercan, Y.
    Adamhasan, F.
    Dilek, O.
    Yilmaz, C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S143 - S144
  • [22] CSF EVALUATION IN ORDER TO PREDICT SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA | A MONOCENTRIC STUDY ON BIOCHEMICAL ANALYSIS AND FLOW CYTOMETRY
    Alma, E.
    Ladiana, R.
    Bellesi, S.
    Maiolo, E.
    Malafronte, R.
    Bellisario, F.
    Innocenzo, S. D'
    Toscano, A.
    D'alo, F.
    Hohaus, S.
    HAEMATOLOGICA, 2024, 109 : 99 - 100
  • [23] Incidence and Risk Factors for Central Nervous System (CNS) Relapse In Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis with Competing Risk Regression (CRR) Model
    Chihara, Dai
    Oki, Ysuhiro
    Matsuo, Keitaro
    Onoda, Hiroshi
    Taji, Hirofumi
    BLOOD, 2010, 116 (21) : 1691 - 1691
  • [24] Treatment outcome for primary mediastinal B-cell lymphoma: a retrospective analysis of 52 patients
    Rieger, M
    Hegenbart, U
    Sitter, S
    Kramer, A
    Witzens, M
    Dreger, P
    Ho, AD
    Hensel, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S236 - S236
  • [25] Prognosis of Patients with Diffuse Large B Cell Lymphoma with Central Nervous System Relapse: USC Experience
    Kaplan, Lucas Avalon
    McLain, Julian Hardy
    Ali, Amir
    Myint, Zaw Win
    Tulpule, Anil
    BLOOD, 2023, 142
  • [26] ANALYSIS OF RISK FACTORS FOR CENTRAL NERVOUS SYSTEM RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: THE EXPERIENCE OF A TERTIARY HOSPITAL
    Vara, M.
    Puente, M.
    Amutio, E.
    Balerdi, A.
    Olazabal, I.
    Diez, H.
    Posada, L.
    Gomez, C.
    Martin, X.
    Martinez-Indart, L.
    Escudero, J.
    Gil, M. A.
    Garcia-Ruiz, J.
    HAEMATOLOGICA, 2016, 101 : 704 - 704
  • [27] Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
    Zhang, Jing
    Chen, Bobin
    Xu, Xiaoping
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 509 - 514
  • [28] Central nervous system relapse in diffuse large B-cell lymphoma: analysis of risk factors and a new prognostic model
    Kanemasa, Yusuke
    Shimoyama, Tatsu
    Sasaki, Yuki
    Takeshi, Sawada
    Sasaki, Eisaku
    Omuro, Yasushi
    Maeda, Yoshiharu
    Hishima, Tsunekazu
    Sasaki, Tsuneo
    ANNALS OF ONCOLOGY, 2015, 26 : 85 - 86
  • [29] Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis
    Bai, Si-Jun
    He, Jian-Xia
    Zheng, Yuan-Jun
    Geng, Ye
    Gao, Yi-Nan
    Zhang, Cai-Xia
    Wang, Ya-Ru
    Qin, Li-Yuan
    Wang, Wen-Jun
    Yang, Lin-Hua
    ANNALS OF HEMATOLOGY, 2024, 103 (11) : 4649 - 4660
  • [30] Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies
    Cabannes-Hamy, Aurelie
    Peyrade, Frederic
    Jardin, Fabrice
    Emile, Jean-Francois
    Delwail, Vincent
    Mounier, Nicolas
    Haioun, Corinne
    Perrot, Aurore
    Fitoussi, Olivier
    Lara, Diane
    Delarue, Richard
    Andre, Marc
    Offner, Fritz
    Ghesquieres, Herve
    Pascal, Laurent
    Soussain, Carole
    Lazarovici, Julien
    Schiano, Jean-Marc
    Gaulard, Philippe
    Tilly, Herve
    Thieblemont, Catherine
    CANCER MEDICINE, 2018, 7 (03): : 539 - 548
12345